We utilize our expertise in design, standardisation and assay validation to develop diagnostics with superior performance. Along with our ongoing research in conventional diagnostic platforms, our core team works on futuristic platforms such as microfluidics and multiplex assays. Our dedicated team works on developing technologies for early cancer detection that can improve treatment efficiency manifold.
Ubio has active research collaborations with world's leading biomedical and healthcare research Institutions. ubio is also actively working on developing low-cost veterinary rapid tests that can increase the use of diagnostics in animal healthcare in developing countries. These products would lower costs of animal care and farm management, and increase the accuracy and quality of treatment, driving down total costs for livestock based businesses.